Biotech ETFs can Cope With the new White House

The healthcare sector was a laggard last year, but the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB), SPDR S&P Biotech ETF (NYSEArca: XBI) and other biotechnology exchange traded funds are shaking out of that slumber with some solid gains in 2017’s early stages. Healthcare stocks and ETFs rallied immediately following Republican Donald Trump’s surprising November victory.…Click to read more at ETFtrends.com.